NA
FBT icon

NewEdge Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

NewEdge Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.6M Buy
62,524
+56,629
+961% +$11.7M 0.05% 392
2025
Q4 		$1.22M Sell
5,895
-108
-2% -$21.6K ﹤0.01% 1362
2025
Q3 		$1.08M Buy
6,003
+522
+10% +$88.9K ﹤0.01% 1363
2025
Q2 		$884K Buy
5,481
+496
+10% +$79K ﹤0.01% 1360
2025
Q1 		$848K Sell
4,985
-9,619
-66% -$1.67M 0.01% 1275
2024
Q4 		$2.43M Buy
14,604
+1,582
+12% +$270K 0.01% 751
2024
Q3 		$2.24M Sell
13,022
-142
-1% -$23.5K 0.01% 739
2024
Q2 		$2.03M Buy
13,164
+9,360
+246% +$1.4M 0.01% 743
2024
Q1 		$585K Sell
3,804
-11,106
-74% -$1.69M 0.01% 1248
2023
Q4 		$2.3M Sell
14,910
-3,069
-17% -$441K 0.02% 617
2023
Q3 		$2.63M Sell
17,979
-943
-5% -$144K 0.03% 504
2023
Q2 		$2.9M Sell
18,922
-5,677
-23% -$885K 0.03% 463
2023
Q1 		$3.81M Sell
24,599
-238
-1% -$37.4K 0.05% 352
2022
Q4 		$3.58M Buy
24,837
+21,503
+645% +$3.17M 0.1% 226
2022
Q3 		$440K Sell
3,334
-1,027
-24% -$144K 0.01% 1028
2022
Q2 		$591K Buy
+4,361
New +$601K 0.01% 910
2022
Q1 		– Sell
-5,736
Closed -$929K – 1315
2021
Q4 		$929K Buy
5,736
+3,353
+141% +$542K 0.01% 771
2021
Q3 		$396K Buy
2,383
+309
+15% +$52.8K 0.01% 812
2021
Q2 		$358K Buy
2,074
+262
+14% +$43.3K 0.01% 832
2021
Q1 		$291K Buy
+1,812
New +$310K 0.01% 824
2020
Q3 		– Sell
-3,111
Closed -$522K – 940
2020
Q2 		$522K Buy
3,111
+804
+35% +$126K 0.02% 528
2020
Q1 		$302K Buy
2,307
+150
+7% +$21.4K 0.01% 599
2019
Q4 		$320K Sell
2,157
-1,656
-43% -$227K 0.01% 643
2019
Q3 		$472K Sell
3,813
-51,374
-93% -$6.84M 0.02% 510
2019
Q2 		$7.77M Buy
55,187
+1,395
+3% +$193K 0.48% 57
2019
Q1 		$8.12M Buy
53,792
+9,588
+22% +$1.38M 0.52% 50
2018
Q4 		$5.49K Buy
44,204
+5,910
+15% +$808K 0.35% 73
2018
Q3 		$6.07M Buy
38,294
+36,715
+2,325% +$5.56M 0.47% 56
2018
Q2 		$223 Sell
1,579
-430
-21% -$59K 0.02% 489
2018
Q1 		$254K Buy
2,009
+136
+7% +$18.6K 0.03% 394
2017
Q4 		$237K Buy
+1,873
New +$231K 0.03% 359
2017
Q3 		– Sell
-1,314
Closed -$149K – 610
2017
Q2 		$149K Buy
+1,314
New +$141K 0.03% 358
2016
Q1 		– Sell
-37,657
Closed -$4.26M – 54
2015
Q4 		$4.26M Buy
37,657
+26,572
+240% +$2.86M 3.51% 4
2015
Q3 		$1.13M Sell
11,085
-23,510
-68% -$2.8M 1.21% 33
2015
Q2 		$4.29M Buy
34,595
+1,655
+5% +$200K 3.64% 4
2015
Q1 		$3.89M Buy
32,940
+4,243
+15% +$480K 2.77% 6
2014
Q4 		$2.93M Buy
+28,697
New +$2.8M 2.27% 10

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

NewEdge Advisors's FBT Position: Q1 2026 in Review

NewEdge Advisors increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 961% in Q1 2026, buying an estimated $11.7M and bringing the position to 62,524 shares worth $12.6M. The position accounts for 0.05% of the portfolio, ranked #392.

NewEdge Advisors first reported a position in FBT in Q4 2014 and has held it in 37 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • NewEdge Advisors held 62,524 shares of First Trust NYSE Arca Biotechnology Index Fund worth $12.6M as of Q1 2026.
  • NewEdge Advisors bought 56,629 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $11.7M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of NewEdge Advisors's portfolio in Q1 2026, its #392 holding.
  • NewEdge Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and has held it in 37 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.